RY 152.64 -0.722% TD 79.42 -0.3638% SHOP 86.76 0.2311% CNR 165.66 -0.2529% ENB 50.17 0.8645% CP 114.78 0.4463% BMO 119.46 0.395% TRI 223.44 -0.1118% CNQ 48.32 -1.2265% BN 63.27 -0.1263% ATD 82.05 -0.231% CSU 4214.73 0.4019% BNS 64.16 -1.1707% CM 68.67 0.0146% SU 52.85 -0.7139% TRP 56.41 2.0441% NGT 64.6 -0.9202% WCN 247.72 -0.394% MFC 35.62 -0.6138% BCE 45.62 -0.2405%

Carebook Technologies Inc

Healthcare CA CRBK

0.08CAD
-(-%)

Last update at 2024-07-19T13:30:00Z

Day Range

0.080.08
LowHigh

52 Week Range

0.060.10
LowHigh

Fundamentals

  • Previous Close 0.08
  • Market Cap7.19M
  • Volume0
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-3.38600M
  • Revenue TTM11.16M
  • Revenue Per Share TTM0.12
  • Gross Profit TTM 3.24M
  • Diluted EPS TTM-0.2

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-09-30 2021-09-30 2020-09-30 2019-09-30 2018-09-30
Type yearly yearly yearly yearly yearly
Date 2022-09-30 2021-09-30 2020-09-30 2019-09-30 2018-09-30
Income before tax -19.09800M -19.68800M -0.50449M -0.14105M -
Minority interest - - - - -
Net income -17.81800M -19.28900M -0.50449M -0.14105M -
Selling general administrative 5.71M 7.77M 0.36M 0.14M -
Selling and marketing expenses - - - - -
Gross profit 7.64M 5.12M 3.24M - -
Reconciled depreciation 2.09M 1.13M 0.41M - -
Ebit - - -7.47200M -1.87600M -2.12066M
Ebitda -16.21400M -18.10000M -0.50263M -0.14105M -
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -6.23700M -10.32500M -0.36043M -0.14105M -
Other operating expenses - - - 0.04M 0.03M
Interest expense 0.79M 0.46M 0.00186M 0.00000M 0.00000M
Tax provision -1.28000M -0.39900M - - -
Interest income - - - - -
Net interest income -1.08200M -0.73300M -0.00186M 0.00000M -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -1.28000M - - - -
Total revenue 9.25M 5.74M 3.53M 0.00000M -
Total operating expenses 15.49M 16.06M 0.36M 0.14M -
Cost of revenue 1.62M 0.61M 0.29M - -
Total other income expense net -11.77900M -8.63000M -0.14220M - -
Discontinued operations - - - - -
Net income from continuing ops -17.81800M -19.28900M -0.50449M -0.14105M -
Net income applicable to common shares - - -10.89300M -3.11400M -2.53610M
Preferred stock and other adjustments - - - - -
Breakdown 2022-09-30 2021-09-30 2020-09-30 2019-09-30 2018-09-30
Type yearly yearly yearly yearly yearly
Date 2022-09-30 2021-09-30 2020-09-30 2019-09-30 2018-09-30
Total assets 9.26M 25.59M 0.46M 0.41M -
Intangible assets 6.81M 10.13M - - -
Earning assets - - - - -
Other current assets - - - - -
Total liab 15.62M 19.18M 0.01000M 0.02M -
Total stockholder equity -6.93100M 6.41M 0.45M 0.40M -
Deferred long term liab - - - - -
Other current liab 2.14M 5.31M 1.10M 0.48M 0.53M
Common stock 43.48M - 23.66M 8.12M 7.01M
Capital stock 43.48M 39.07M 1.02M 0.53M -
Retained earnings -64.33500M -46.51700M -27.22800M -16.33700M -13.22298M
Other liab - - - 1.11M 0.38M
Good will 0.00000M 11.11M 4.37M - -
Other assets - - - 0.01000M 0.01000M
Cash 0.74M 1.46M 0.44M 0.25M -
Cash and equivalents - - - - -
Total current liabilities 9.59M 13.46M 1.68M 4.07M 3.78M
Current deferred revenue - - - - -
Net debt 7.07M 6.54M - - -
Short term debt - - - - -
Short long term debt 4.16M 7.00M - - -
Short long term debt total - - - - -
Other stockholder equity - - 2.42M - -
Property plant equipment - 0.94M 0.84M 0.77M 0.86M
Total current assets 1.77M 3.26M 3.98M 0.18M 0.20M
Long term investments - - - - -
Net tangible assets - -14.83500M 2.47M -7.35100M -5.99084M
Short term investments - - - - -
Net receivables 0.76M 1.06M 0.24M 0.00400M 0.09M
Long term debt 3.65M 1.00M - - -
Inventory - - - - -
Accounts payable 1.36M 0.80M 0.37M 0.11M 0.39M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 7.49M 22.34M 5.21M 0.14M -
Capital lease obligations 0.70M 0.82M 0.74M - -
Long term debt total - - - - -
Breakdown 2022-09-30 2021-09-30 2020-09-30 2019-09-30 2018-09-30
Type yearly yearly yearly yearly yearly
Date 2022-09-30 2021-09-30 2020-09-30 2019-09-30 2018-09-30
Investments -2.17100M -12.21600M 0.02M -0.01000M -
Change to liabilities 0.30M 0.00000M 0.94M -0.31300M 0.55M
Total cashflows from investing activities - - -0.05600M -0.04900M -0.47232M
Net borrowings - - -5.85700M 0.56M 1.26M
Total cash from financing activities 4.21M 4.21M 8.91M 1.43M 1.45M
Change to operating activities - - -0.05300M -0.04300M 0.00079M
Net income -17.81800M -19.28900M -10.89300M -3.11400M -2.53610M
Change in cash -0.71500M -2.17300M 3.51M 0.03M 0.04M
Begin period cash flow 1.46M 3.63M 0.25M 0.08M -
End period cash flow 0.74M 1.46M 0.44M 0.25M 0.08M
Total cash from operating activities -2.74900M -7.26200M -5.34600M -1.35400M -0.93269M
Issuance of capital stock 4.50M 11.28M 0.17M 0.38M -
Depreciation 2.09M 0.35M 0.41M 0.79M 0.76M
Other cashflows from investing activities - - - - -
Dividends paid 0.00000M 0.00000M 0.00000M - -
Change to inventory - - - - -
Change to account receivables - - -0.23200M 0.09M 0.08M
Sale purchase of stock - - - - -
Other cashflows from financing activities - - -7.39800M -0.23300M 0.19M
Change to netincome - - 4.49M 1.24M 0.22M
Capital expenditures 0.00000M 0.17M 0.06M 0.05M 0.47M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.80M 1.39M -0.01710M -0.06881M -
Stock based compensation 0.05M 1.24M 0.07M 0.00000M -
Other non cash items 0.80M 0.92M 0.43M - -
Free cash flow -2.74900M -7.43600M -0.31350M -0.21985M -

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CRBK
Carebook Technologies Inc
- -% 0.08 - 28.57 0.64 1.58 1.34 -1.2167
RHT
Reliq Health Technologies Inc
- -% 0.21 - - 3.19 5.12 4.07 -10.7759
ADK
Diagnos Inc
-0.015 4.55% 0.32 - 9.75 99.08 54.61 112.33 -13.5942
NURS
Hydreight Technologies Inc
0.01 3.39% 0.30 - - 1.33 - 1.08 -1.7505
NEWU
Newtopia Inc
- -% 0.04 - - 1.13 116.97 2.00 -6.0385

Reports Covered

Stock Research & News

Profile

Carebook Technologies Inc. engages in the development and commercialization of digital health platforms worldwide. The company offers Corehealth, a wellness platform for employers, and wellness and service providers; Wellness Checkpoint platform that offers health and productivity risk management; and Carebook, a turn-key, modular, and pharmacy engagement platform. Carebook Technologies Inc. is headquartered in Montreal, Canada.

Carebook Technologies Inc

1400-2045 Stanley Street, Montreal, QC, Canada, H3A 2V4

Key Executives

Name Title Year Born
Dr. Sheldon Elman M.D. Exec. Chairman NA
Mr. Michael Peters Chief Exec. Officer NA
Mr. Mathieu Lampron Chief Operating & Product Officer NA
Mr. Olivier Giner Chief Financial Officer NA
Ms. Stephanie Saheb VP of Operations NA
Mr. Charles Martin Chief Technology Officer NA
Mr. Zev Zelman Corp. Sec. NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.